Ira Goldfine

Endocrinology in San Francisco, California

Practice Details

Address
400 Parnassus Ave
San Francisco, CA 94143
Geocoded location: 37.7636, -122.4576
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
MD
NPPES Enumeration
Listed with NPPES since 2006
Provider Gender (NPPES)
Male
NPPES Record Updated
September 2025

Specialty taxonomies on file (2)

  • Internal Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 93 Endocrinology, Diabetes & Metabolism practices in San Francisco carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Ira Goldfine's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 415-353-2350.

GLP-1 access in San Francisco, California

Adult obesity rate
28.1%
#44 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$219/mo
Typical California telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
California Medicaid, obesity indication

About 28.1% of California adults have obesity (BMI 30+), ranking the state #44 of 50 (CDC BRFSS). Our directory currently lists 144 GLP-1-relevant clinics in San Francisco. If a cash-pay route makes more sense, compounded semaglutide through California telehealth averages about $219/mo — well below brand-name Wegovy or Zepbound.

Explore more California options on the best California GLP-1 providers page, browse every San Francisco listing in the San Francisco clinic directory.

Related Practices in San Francisco

Other San Francisco listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to California addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured California telehealth partners:

Featured Partners · San Francisco

Featured GLP-1 providers serving San Francisco

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  2. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  3. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  4. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  5. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →

See more San Francisco options on the San Francisco clinic directory, our San Francisco GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by San Francisco obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Ira Goldfine's specialty taxonomy but not the specific medications it prescribes or its current service menu. Ira Goldfine is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 415-353-2350 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Ira Goldfine's primary specialty on file is Endocrinology.
Ira Goldfine is located at 400 Parnassus Ave, San Francisco, CA 94143. The phone number listed in the registry is 415-353-2350. Its full record is public in the CMS National Provider registry under NPI 1508823675.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Ira Goldfine is currently accepting new patients. Call the practice at 415-353-2350 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.